Newsroom

Sorted by: Latest

-

EOLA Power Posts 79% Growth, Lands on Inc. 5000 Regionals Two Years Running

MIAMI--(BUSINESS WIRE)--EOLA Power, a nationwide provider of critical power and UPS systems, has been named to the 2026 Inc. 5000 Regionals: Southeast list of fastest-growing private companies, posting 79% two-year revenue growth and ranking No. 101 in the region. The recognition reflects sustained momentum for the company as demand grows for reliable critical power across data centers, healthcare, hospitality, sports, and federal markets. The Inc. 5000 Regionals honors the fastest-growing priv...
-

ViewSonic Showcases Large Scale Display Solutions with Various Direct View LED Products at InfoComm 2026

LAS VEGAS--(BUSINESS WIRE)--ViewSonic Showcases Large Scale Display Solutions with Various Direct View LED Products from MIP Technology to Industry-Leading Mobile Solutions...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 17.06.2026 FGOV LN IE00BKS2X200 108,638.00 GBP 1,619,578.28 17.228  ...
-

AGMRI AI Agent Now in Use for Field-Level Agronomic Decisions

INDIANAPOLIS--(BUSINESS WIRE)--Intelinair has launched the AGMRI AI Agent, an AI capability inside the AGMRI platform that lets agronomic advisors and growers ask questions and receive field-level answers in seconds. Now live, the AGMRI AI Agent is built on the agronomic data already in AGMRI: multi-source imagery, soil characteristics, weather, input applications, field boundaries, and historical yield outcomes.The AGMRI AI Agent is purpose-built for agronomy, not adapted from a general-purpose...
-

Nortiva Bio Launches to Develop Long-Acting Oral Medicines

LEXINGTON, Mass.--(BUSINESS WIRE)--Nortiva Bio, Inc. (“Nortiva”) today announced its launch as a clinical-stage biopharmaceutical company dedicated to developing long-acting oral medicines using its proprietary LYNX™ drug delivery platform. Nortiva’s LYNX platform can transform daily pills into long-acting oral therapies with single doses that last up to a month in multiple therapeutic areas. This advancement can optimize efficacy and safety, improve medication adherence, and positively impact...
-

Alight Announces Reverse Stock Split Ratio of 1-for-20 and Expected Effective Date of June 30, 2026

CHICAGO--(BUSINESS WIRE)--Alight, Inc. (NYSE: ALIT), a leading benefits administration provider of health, wealth and leave solutions, today announced its Board of Directors has determined to effectuate a reverse stock split of Alight’s outstanding shares of common stock and a corresponding decrease in the number of authorized shares of each class and series of common stock (the “Reverse Stock Split”) at a ratio of 1-for-20. The Reverse Stock Split was approved by stockholders at Alight’s 2026 A...
-

Ulta Beauty Launches New NielsenIQ Study on Gen Alpha and AI-Powered Beauty Discovery

BOLINGBROOK, Ill.--(BUSINESS WIRE)--Ulta Beauty, Inc. (NASDAQ: ULTA) today unveiled findings from a new Ulta Beauty-commissioned study conducted by NielsenIQ, “Smart Beauty: AI, Personalization & the Gen Alpha Consumer,” exploring how Gen Alpha consumers are navigating beauty and wellness in an increasingly AI-driven world. The study underscores Ulta Beauty’s commitment to understanding and evolving alongside the next generation, as well as building beauty and wellness experiences that are...
-

FIS Sweeps All Three Chartis Enterprise Market Risk Quadrants in 2026

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Global financial technology leader FIS® has been named a Category Leader across all three quadrants in the Chartis Enterprise Market Risk Solutions, 2026 Quadrant Update, positioning FIS as one of the few providers capable of serving the full breadth of enterprise market risk needs from a single integrated platform. The Chartis report analyzes the global vendor landscape for enterprise market risk management technologies used by financial institutions. Vendo...
-

Scribe Therapeutics Awarded More Than $25 Million From CIRM to Accelerate Additional CRISPR-Based Gene Editing Therapies for Cardiometabolic Disease Into Clinical Trials

ALAMEDA, Calif.--(BUSINESS WIRE)--Scribe awarded more than $25M from CIRM to accelerate additional CRISPR-based gene editing therapies for cardiometabolic disease into clinical trials...
-

Proof Over Promises: UPS's Bold AI Initiatives Enhance Products, Services and Customer Experience

ATLANTA--(BUSINESS WIRE)--For more than three years, UPS (NYSE: UPS) has strategically deployed AI to transform global logistics. Today, the company is detailing AI-powered solutions that combine the expertise of its approximately 460,000 employees with technology to shape the future of UPS. These initiatives advance a companywide priority: simplification. UPS is scaling AI, automation and advanced analytics to improve end-to-end visibility and the overall customer experience; make its global l...